IDH1 and cancer: Further characterization of IDH-mutant cancer cells by our group and others led to the discovery that 2HG causes a DNA repair defect through alteration of DNA repair factor recruitment to sites of DNA damage, conferring vulnerability to DNA repair inhibitors, including poly (ADP-ribose) polymerase inhibitors (PARPi) [2–4].